Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatoline for local adiposity and cellulite (Phase IV, single-arm study)
2020-003740-89Phase 4Completed
- Sponsor
- Manetti & Roberts
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Somatoline in cellulite and localized adiposity (AL), sponsored by Manetti & Roberts. Primary endpoint: Primary: CSS score improvement at 28 days. Started May 2021; status: completed.
02
Drugs
Somatoline
03
Conditions
cellulitelocalized adiposity (AL)
Beyond the preview
Go deeper on 2020-003740-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003740-89.